Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response (AMELIORATE)
This study is currently recruiting participants.
Verified February 2013 by Hospital Clinic of Barcelona
Study NCT01530711   Information provided by Hospital Clinic of Barcelona

First Received on February 9, 2012.   Last Updated on February 27, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cirrhosis
Hepatorenal Syndrome Type I
Additional conditions recognized in this trial
Fibrosis
Hepatorenal Syndrome
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Kidney Diseases
Liver Diseases
Pathologic Processes
Urologic Diseases
Interventions listed in this trial
Terlipressin and albumin
Additional drug interventions recognized in this trial
Lypressin
Terlipressin
More general drug interventions related to this trial
Antidiuretic Agents
Antihypertensive Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Pere Gines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services